Tweenvest Stocks

Boule Diagnostics AB (publ) (OM: BOUL)

Health Care · Health Care Equipment & Supplies · SE

Skr3.13

-3.69% today · -48.1% 1Y

Boule Diagnostics AB (publ) (OM: BOUL) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $13.33M and employs 200 people.

Over the last twelve months the share price has lost 48.1%, trading between 2.75 and 6.64.

Tweenvest scores Boule Diagnostics AB (publ) across four factors: quality 63/100, value 61/100, growth 14/100. Its strongest factor is quality.

BOUL price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$13.33M
Revenue (TTM)
$47.60M
P/E
EPS
-0.08
Dividend yield
Beta (5Y)
0.19
52-week high
Skr6.64
52-week low
Skr2.75
Avg volume (3M)
Shares outstanding
38.83M
Employees
200
Next earnings

About Boule Diagnostics AB (publ)

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.

ISIN
SE0011231158
Founded
1956
Listed since
Jun 23, 2011
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
Abbott LaboratoriesNYSE: ABT$200.95B$115.12-0.87%
Intuitive Surgical, Inc.NasdaqGS: ISRG$131.36B$369.83-0.54%
Stryker CorporationNYSE: SYK$126.81B$331.82+0.37%
Medtronic plcNYSE: MDT$116.66B$92.13+1.09%
EssilorLuxottica Société anonymeENXTPA: EL$85.36B159.20+0.03%
Boston Scientific CorporationNYSE: BSX$72.26B$48.24-3.26%
HOYA CorporationTSE: 7741$52.49B¥24,995.00+0.40%
Edwards Lifesciences CorporationNYSE: EW$52.38B$91.09+0.24%

Browse every Health Care Equipment & Supplies company →

Figures last refreshed Aug 18, 2026.